Market access rebates for brand medicines by component U.S. 2020

Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)

Market access rebates and discounts for brand medicines by component U.S. 2013-2020

Last update:

Jan 31, 2022

Author:

��ƽ�� Research Department

Region:

United States

Survey time period:

From 01/01/2013 to 31/12/2020

In 2020, market access rebates and discounts as a subcomponent of gross expenditures for brand medicines accounted for more than 102 billion U.S. dollars in the United States. The statistic illustrates the total market access rebates and discounts for brand medicines by components from 2013 to 2020, by component.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)

Get in touch with us for additional information

��ƽ��